China Researchers Develop First Oral Vaccine Against Gastric Cancer
This article was originally published in PharmAsia News
Chinese scientists report creation of the first oral vaccine to guard against gastric cancer. The Ministry of Science and Technology said the vaccine blocks stomach bacteria believed linked to development of duodenal and gastric ulcers as well as stomach cancer. The bacteria involved is Helicobactor pylori, defeated by the vaccine so far through Phase III trials, earning it the China State FDA's "first-grade new medicine" status. The vaccine, which already has intellectual property rights protection, demonstrated a 72.1 percent protection rate against Hp bacteria. (Click here for more
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.